Syngenta deal could pave way for biotech acceptance from China users

SINGAPORE (Reuters) - ChemChina's purchase of Syngenta could remove some of the suspicion around genetically modified crops and ultimately lead to more rapid user acceptance of biotechnology in food production in China, Syngenta's Chief Operating Officer Davor Pisk told Reuters.











Read more